Khosla Ventures ‘
Prellis Biologics has raised $8.7M
According to Dr. Alex Morgan, Principal at Khosla Ventures and Dr. Melanie Matheu, Prellis Biologics’ co-founder and CEO, “Regenerative medicine has made enormous leaps in recent decades. However, to create complete organs, we need to build higher-order structures like the vascular system. Prellis’ optical technology provides the scaffolding necessary to engineer these larger masses of tissues. With our investment in Prellis, we’re supporting an initiative that will ultimately produce a functioning lobe of the lung, or even a kidney, to be used in addressing an enormous unmet global need.
The human tissue engineering is the ability to build complex tissues with working vascular systems. The future of regenerative medicine revolves around harnessing the power of our own cells as therapeutics and building the tissues to keep them alive. Khosla Ventures is the perfect investor to support our merging of deep tech and cutting-edge regenerative medicine. With this technology in hand, we can begin to ask questions about real 3D cell biology that have never been asked before.”
https://www.prellisbio.com/
https://www.eurekalert.org/
This entry was posted in 3D Print Biotechnology and medicine articles, 3D Printer Company, 3D Printer material types, 3D Printer Patents, Research and Innovations, 3D printers next big industrial thing, 3D Printing and healthcare, 3D Printing Entrepreneur, 3D Printing for saving humanity, 3D Printing in Medicine and Health, 3D Printing Industry News and trends, 3D printing material learning and exploring, 3D Printing possibilities for future, 3D Printing research and education, 3D Scientific Inquiry and Research, Biocompatibility tests for 3D printing, Complex Geometry in additive manufacturing design, Design: Design, Grant and funding for 3D printing, SV3DPrinter solutions and prediction for 3d Printing market, SV3DPrinter's 'Must see posts', SV3DPrinter.com Policy, SV3DPrinter’s vision for future 3D printers, The future of 3D 4D 5D printing services, Tools to achieve the 3D 4D 5D Print creation and tagged Biotech Showcase in San Francisco., Dr. Alex Morgan, Dr. Melanie Matheu, Khosla Ventures ', Prellis Biologics has raised $8.7M, Prellis Biologics', Regenerative medicine, vascular system.